Bosentan and Pulmonary Endothelial Function
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Spironolactone for Pulmonary Arterial Hypertension
- Status
- RECRUITING
- Phase
- PHASE2
Adult Congenital Heart Disease Registry (QuERI)
- Status
- COMPLETED
- Phase
- N/A
Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost
- Status
- UNKNOWN
- Phase
- PHASE4
FK506 (Tacrolimus) in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- NA
Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Eisenmenger Quality Enhancement Research Initiative
- Status
- COMPLETED
- Phase
- N/A
Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain
- Status
- WITHDRAWN
- Phase
- PHASE4
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
- Status
- COMPLETED
- Phase
- NA
Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers
- Status
- COMPLETED
- Phase
- N/A
Remodulin® to Oral Treprostinil Transition
- Status
- COMPLETED
- Phase
- PHASE2
An Open Label Access Study For Subjects Who Completed A1481156
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- NA
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Inhaled Treprostinil for PAH: Open-label Extension
- Status
- WITHDRAWN
- Phase
- PHASE3
Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
- Status
- WITHDRAWN
- Phase
- PHASE3